SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,776,646 | -26.5% | 41,370 | -33.3% | 0.50% | -24.5% |
| Q2 2023 | $11,942,335 | -51.5% | 62,051 | -48.9% | 0.67% | -54.6% |
| Q1 2023 | $24,605,977 | +67.5% | 121,529 | +6.3% | 1.48% | +45.6% |
| Q4 2022 | $14,690,621 | -1.4% | 114,315 | +5.0% | 1.01% | -2.5% |
| Q3 2022 | $14,902,000 | +4.1% | 108,909 | +34.6% | 1.04% | -3.6% |
| Q2 2022 | $14,318,000 | +23.8% | 80,918 | +0.8% | 1.08% | +63.6% |
| Q1 2022 | $11,561,000 | +44.1% | 80,256 | +54.7% | 0.66% | +61.9% |
| Q4 2021 | $8,022,000 | -8.5% | 51,889 | +0.5% | 0.41% | -14.7% |
| Q3 2021 | $8,765,000 | -14.9% | 51,619 | -20.9% | 0.48% | -15.9% |
| Q2 2021 | $10,300,000 | +8.0% | 65,241 | -5.0% | 0.57% | -1.6% |
| Q1 2021 | $9,538,000 | -23.9% | 68,689 | -4.0% | 0.58% | -21.3% |
| Q4 2020 | $12,532,000 | – | 71,557 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |